Sima Sistani, CEO of WeightWatchers, announced her departure from the weight-loss company, which has struggled to adapt in ...

The digital service will keep Mount Sinai physicians updated on patients' progress, allowing them to improve care decisions.

Noom will submit an official statement to the congressional record at Tuesday’s Senate hearing with three specific recommendations calling for ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

The companies want to open up a two-way referral channel between one another in hopes of filling gaps in treatment.

Mount Sinai Health System is teaming up with a major venture-backed company aimed at behavioral approaches to weight loss.

Online companies like Noom and Hims & Hers this year began selling compounded semaglutide, the active ingredient in Ozempic ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

The shortage of popular diabetes and weight-loss drugs known as GLP-1s — and insurers’ uneven coverage of them — is putting an unprecedented supply of compounded drugs in consumers' medicine cabinets.

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

Subscribe today to gain access to every Research Intelligencer article we publish as well as the exclusive daily newsletter, ...